Sort by
Refine Your Search
-
spectrometry-based proteomics to understand how proteins, their interactions, and their modifications drive disease and drug response, and we develop the methods to address these questions across basic, clinical
-
Assessment and non-animal methods (NAMs). We combine in vitro molecular biology, mass-spectrometry-based proteomics, bioinformatics, evidence synthesis and computational modelling to understand how
-
Finland covering more than five billion healthcare events, FinnGen with genomic data from over 500,000 participants, and extensive multi-omics datasets including proteomics and single-cell transcriptomics
-
proteomics and single-cell transcriptomics. Researchers also benefit from access to world-class computing infrastructure through CSC and LUMI, one of Europe's most powerful supercomputers. RESPONSIBILITIES
-
Finland covering more than five billion healthcare events, FinnGen with genomic data from over 500,000 participants, and extensive multi-omics datasets including proteomics and single-cell transcriptomics